BMED vs SCHD
iShares Health Innovation Active ETF vs Schwab US Dividend Equity ETF
Quick Verdict
SCHD has a lower expense ratio. SCHD delivered stronger 1-year returns. SCHD offers more diversification with 100 holdings.
Side-by-Side Comparison
| Metric | BMED | SCHD | Winner |
|---|---|---|---|
| Expense Ratio | 0.55% | 0.06% | |
| AUM | $11M | $103.7B | |
| Dividend Yield | 0.27% | 3.31% | |
| Holdings | 56 | 104 | |
| YTD Return | +6.89% | +26.21% | |
| 1Y Return | +26.80% | +29.99% | |
| 3Y Return (annualized) | +10.58% | +15.73% | |
| 5Y Return (annualized) | +2.00% | +9.67% | |
| Volatility (annualized) | 16.9% | 13.6% | |
| Max Drawdown | -36.4% | -33.4% | |
| Fund Family | BlackRock, Inc. (US) | Charles Schwab Asset Management | |
| Category | Equity | Equity | |
| Inception | Sep 29, 2020 | Oct 20, 2011 |
BMED vs SCHD Performance
iShares Health Innovation Active ETF (BMED) is a ETF from BlackRock, Inc. (US) and Schwab US Dividend Equity ETF (SCHD) is a ETF from Charles Schwab Asset Management. Over the past year BMED returned +26.80% while SCHD returned +29.99%. Year to date, BMED is up 6.89% versus a gain of 26.21% for SCHD.
Over three years, BMED compounded at +10.58% per year against +15.73% for SCHD; over five years the annualized figures are +2.00% and +9.67% respectively. Across the full 6-year window we track, SCHD has the edge at +11.50% annualized vs +4.18%. Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
BMED has been the more volatile fund, with annualized monthly volatility of 16.9% compared with 13.6% for SCHD. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -36.4% for BMED and -33.4% for SCHD. Drawdown depth is worth weighing if you expect to sell during market stress rather than ride it out.
The two funds' monthly returns correlate at 0.59. They move independently enough that combining them can meaningfully diversify a portfolio.
Fees and Cost Over Time
BMED charges 0.55% per year while SCHD charges 0.06%. On a $10,000 position that is $55 vs $6 annually, a gap of $49 per year that compounds over a long holding period. On income, BMED currently yields 0.27% against 3.31% for SCHD.
Holdings Overlap
BMED and SCHD share 3 holdings out of 147 unique holdings combined, representing a 9.6% weight overlap.
Moderate overlap means holding both could provide meaningful diversification benefits.
Frequently Asked Questions
Which is cheaper, BMED or SCHD?
BMED has an expense ratio of 0.55% while SCHD charges 0.06%. SCHD is the cheaper option. On a $10,000 investment, that is $49 per year of difference.
Which performed better, BMED or SCHD?
Over the past year BMED returned +26.80% vs +29.99% for SCHD, so SCHD leads on 1-year performance. Over the longest common window we track (6 years), BMED annualized +4.18% vs +11.50% for SCHD. Past performance does not guarantee future results.
Which is riskier, BMED or SCHD?
BMED has been the more volatile fund at 16.9% annualized versus 13.6% for SCHD. Worst drawdown: BMED -36.4% vs SCHD -33.4%.
Should I hold both BMED and SCHD?
BMED and SCHD have a monthly-return correlation of 0.59, so combining them can provide real diversification depending on your allocation goals.
What is the holdings overlap between BMED and SCHD?
BMED and SCHD share 3 common holdings with a 9.6% weight overlap. Combined, they hold 147 unique securities.
Which pays a higher dividend, BMED or SCHD?
BMED yields 0.27% while SCHD yields 3.31%, so SCHD currently pays the higher dividend yield.
Popular ETF Comparisons
Get Full ETF Analytics
Access complete holdings data, overlap analysis, screener tools, and more with FundXLS.